Om Shah, Founder & CEO of VitaBildung

Om Shah

Founder & CEO, VitaBildung
Medical student Myopia care Health access
om@vitabildung.com →

Om Shah is a medical student and the founder of VitaBildung. His work sits at the intersection of clinical training and a conviction that good eye care shouldn't depend on which clinic a patient happens to walk into.

Like most ideas that end up mattering, VitaBildung didn't start as a business plan. It started as a pattern Om kept noticing: patients with worsening myopia who'd been seen by multiple providers over the years, each offering a different piece of advice, none of it adding up to an actual plan. Some had been told to "just get stronger glasses." Others had never been told that progression could be slowed at all. The clinical knowledge to do better already existed in the literature — it just wasn't reaching the patients who needed it, in a form any provider could actually act on.

"The gap usually isn't medical, it's medicine that didn't reach the right room."

That observation became the starting premise for VitaBildung: build a single, structured pathway — grounded in real clinical evidence — that works whether a patient is sitting across from an ophthalmologist with a full diagnostic suite, or a pharmacist with five minutes and a basic eye chart. Om has spent the time since combining his clinical coursework with independent research into myopia progression biomarkers, working through the evidence base by hand, and translating it into something a non-specialist could actually use at the point of care.

Why this, why now

Myopia is one of the few areas of medicine where the science of slowing a condition is already well-established, but the systems for delivering that science consistently are not. Om sees that gap as the actual opportunity: not inventing new biology, but building the missing layer that gets existing evidence into the hands of the providers who see these patients first — often years before a specialist ever does.

How he works

Om approaches VitaBildung the way he approaches differential diagnosis: start from the evidence, stay honest about what's actually proven versus promising, and never let a clean-looking tool get ahead of the data behind it. That discipline shapes every part of VitaBildung, from the clinical logic in its protocol to how the product is described to clinicians and patients alike.

Mbanisi Lucas Somuto, Co-Founder of VitaBildung

Mbanisi Lucas Somuto

Co-Founder, VitaBildung
Medical student Research Ophthalmology
hello@vitabildung.com →

Mbanisi Lucas Somuto is a medical student, researcher, and co-founder of VitaBildung, where he focuses on bridging clinical research with technology to improve the delivery of evidence-based eye care.

His work centers on ensuring that healthcare professionals have access to practical, data-driven tools that support consistent clinical decision-making and improve patient outcomes. Currently pursuing his medical degree after completing his pre-medical education at AUACAS, Lucas has developed strong interests in ophthalmology, pediatrics, pharmacology, neurology, and translational medical research. Throughout his academic journey, he has participated in research across psychology, physiology, and pharmaceutical sciences, building a multidisciplinary perspective on healthcare innovation.

"Technology should strengthen — not replace — clinical judgment."

At VitaBildung, Lucas contributes to the scientific foundation behind the company's software platform, helping translate current clinical evidence into structured workflows that support healthcare professionals in identifying, monitoring, and managing myopia more effectively. He believes making high-quality evidence more accessible at the point of care is the key to better outcomes.

Looking ahead

Alongside the development of VitaBildung's digital platform, Lucas is also interested in future research exploring novel pharmacological approaches for myopia management, including innovative eye-drop therapies. While this remains a long-term research objective, he views software-driven clinical decision support as the most immediate opportunity to improve patient care and expand access to evidence-based myopia management.

How he works

Lucas is passionate about scientific integrity, interdisciplinary collaboration, and ethical medical innovation. He believes meaningful partnerships between researchers, clinicians, educators, and technology developers are essential for translating scientific discoveries into practical healthcare solutions that can benefit patients worldwide. Beyond research, he is committed to medical education, mentorship, and promoting equitable access to healthcare. As VitaBildung continues to grow, Lucas envisions helping build a research-driven organization that combines clinical evidence, intelligent software, and collaborative research to advance ophthalmic care.

Have a stake in better myopia care?

Whether you're a clinician, researcher, or potential collaborator — we'd like to hear from you.

Get in touch